Cargando…
Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models
At the turn of the last century, the emerging field of medical oncology chose a cytotoxic approach to cancer therapy over an immune-centered approach at a time when evidence in support of either paradigm did not yet exist. Today, nearly 120 years of data have established that (a) even the best cytot...
Autores principales: | Decker, William K., da Silva, Rodrigo F., Sanabria, Mayra H., Angelo, Laura S., Guimarães, Fernando, Burt, Bryan M., Kheradmand, Farrah, Paust, Silke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539135/ https://www.ncbi.nlm.nih.gov/pubmed/28824608 http://dx.doi.org/10.3389/fimmu.2017.00829 |
Ejemplares similares
-
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
por: Zalfa, Cristina, et al.
Publicado: (2021) -
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
por: Li, Wei, et al.
Publicado: (2020) -
AIMp1 Potentiates T(H)1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity
por: Liang, Dan, et al.
Publicado: (2018) -
Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022) -
CXCR6(+) and NKG2C(+) Natural Killer Cells Are Distinct With Unique Phenotypic and Functional Attributes Following Bone Marrow Transplantation
por: Aviles-Padilla, Kevin, et al.
Publicado: (2022)